Elizabeth Holmes made her first public appearance at #AACC2016 where most thought that she would address the concerns (I’m being nice) around the Theranos products and practices. While most believed that Holmes would not go into much detail, I didn’t see anyone predict that she would not only avoid the controversy, but she also decided to launch a new product. I use the phrase “new product” lightly since it’s similar to lab equipment on the market today, but smaller.
I think this image and tweet describes most people’s reaction to this bait and switch by Theranos and Holmes:
Did the @_AACC and everyone else just get "punked" by #Theranos again? Amazing.#HCldr#HITsm pic.twitter.com/X5AJ7nrua5
— Edward Bukstel (@ebukstel) August 1, 2016
It’s too bad she chose not to address the controversy before trying to sell another product. Are there any labs out there that will buy this new product until they do address the controversy? I’d hope not. Theranos will have to address it, but for some reason they’re putting it off.
This tweets seems to have captured the sentiment that most will likely feel about any product that Theranos tries to deliver:
"Fool me once, shame on you. Fool me twice, shame on me." – all I can think after Elizabeth Holmes #Theranos presentation at #AACC2016
— Ade Adamson (@AAdamsonMD) August 1, 2016
